低碳水化合物饮食作为主要抑郁症障碍的营养干预:重点关注复发预防
Michał Walaszek1, Zofia Kachlik1, Wiesław Jerzy Cubała1
1Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland.
Nutritional neuroscience
|January 21, 2024
概括
通过低碳水化合物饮食 (LCD) 和性饮食 (KD) 减少碳水化合物摄入量显示出对管理严重抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 的承诺. 这些饮食策略可以改善情绪并通过准BDNF等关键分子机制来预防复发.
科学领域:
- 营养神经科学 营养神经科学
- 代谢精神病学 代谢精神病学
背景情况:
- 情绪障碍,包括主要抑郁症 (MDD),是全球重要的健康负担.
- 很大一部分MDD患者 (约30%) 患有耐治疗性抑郁症 (TRD),需要新的治疗方法.
- 目前用于MDD和TRD的药理疗法在疗效和患者反应方面存在局限性.
研究的目的:
- 研究碳水化合物限制策略对MDD和TRD的治疗潜力.
- 探索低碳水化合物饮食 (LCHD) 和性饮食 (KD) 对情绪调节的影响的分子机制.
- 评估饮食干预对抑郁症,焦虑症和认知功能症状的影响.
主要方法:
- 进行了全面的文献审查.
- 审查的重点是研究LCHD,KD和含糖饮料 (SSB) 排除对情绪障碍的影响.
- 分析了分子机制,特别是来自大脑的神经营养因子 (BDNF) 的作用.
主要成果:
- 限制碳水化合物摄入量的营养干预措施显示,抑郁和焦虑症状显著减少.
- 这些饮食策略与情绪改善和认知障碍风险降低有关.
- 脑衍生神经营养因子 (BDNF) 被确定为一个关键的分子标,介导糖限制的神经可塑性效应.
结论:
- 低碳水化合物饮食 (LCHD) 策略,包括KD和SSB排除,为管理MDD和TRD提供了一种安全和可实施的方法.
- 这些营养干预措施可能有助于改变疾病的进展,维持心,并预防抑郁的复发.
- 医疗保健专业人员应考虑将LCHD作为MDD和TRD患者的辅助疗法,以改善整体健康和长期结果.
相关概念视频
Binge Eating Disorders
70
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
70
Depression: Overview
247
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
247
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41


